Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04695691 · ClinicalTrials.gov registry record · NA
A Device Study for the Treatment of Acne
A NA study, sponsored by Cutera.
- Completed
- Registry status
- NA
- Development phase
- 104
- Enrollment target
NCT04695691: Completed NA study, sponsored by Cutera.
NCT04695691 is a NA study that has completed, run by Cutera. The registered enrollment target is 104 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04695691, a NA study, has completed, sponsored by Cutera.
- COMPLETED
- Registry status
- NA
- Development phase
- 104 participants
- Enrollment target
Study Summary
To evaluate the safety and efficacy of the Cutera laser system for the treatment of acne vulgaris.
Primary Outcome
Primary effectiveness objective was to show more than 50% of subjects enrolled were Responders who achieved Treatment Success, where Treatment Success was defined as a subject with ≥50% fewer inflammatory acne lesions with respect to baseline
Interventions
- DEVICE Cutera Laser System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2020-12-15 |
| Est. Completion | 2022-12-07 |
| Phase | NA |
What the finished NCT04695691 record still lists
NCT04695691 is an interventional study that assigns participants to a tested intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 1 intervention - of which Cutera Laser System is the first listed.
NCT04695691 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04695691 about?
NCT04695691 is a clinical study titled "A Device Study for the Treatment of Acne". To evaluate the safety and efficacy of the Cutera laser system for the treatment of acne vulgaris.
What is the current status of trial NCT04695691?
This trial is currently completed. It is a NA study. The enrollment target is 104 participants. The study started on 2020-12-15. Estimated completion is 2022-12-07.
What interventions are being tested in trial NCT04695691?
The interventions under investigation include: Cutera Laser System (DEVICE).
Who is sponsoring clinical trial NCT04695691?
This trial is sponsored by Cutera, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04695691's enrollment target sits among peer trials
104 836th of 2000 higher than 1,164 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03403686 · 104 participants
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
- NCT04228367 · 104 participants · NA
JuggerStitch Post Market Clinical Follow-up Study
- NCT04268849 · 104 participants · Phase 3
Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
- NCT04390724 · 104 participants
Optimizing Y90 Therapy for Radiation Lobectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI